关注
Pei-Yong Shi
Pei-Yong Shi
VP, Global Head of Viral Vaccines, GSK
在 utmb.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates
EE Walsh, RW Frenck Jr, AR Falsey, N Kitchin, J Absalon, A Gurtman, ...
New England Journal of Medicine 383 (25), 2439-2450, 2020
26722020
Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure
X Qian, HN Nguyen, MM Song, C Hadiono, SC Ogden, C Hammack, ...
Cell 165 (5), 1238-1254, 2016
19692016
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ...
Nature 586 (7830), 594-599, 2020
18892020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
MJ Mulligan, KE Lyke, N Kitchin, J Absalon, A Gurtman, S Lockhart, ...
Nature 586 (7830), 589-593, 2020
17332020
Spike mutation D614G alters SARS-CoV-2 fitness
JA Plante, Y Liu, J Liu, H Xia, BA Johnson, KG Lokugamage, X Zhang, ...
Nature 592 (7852), 116-121, 2021
16592021
2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members
S Daffis, KJ Szretter, J Schriewer, J Li, S Youn, J Errett, TY Lin, ...
Nature 468 (7322), 452-456, 2010
9412010
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
RE Chen, X Zhang, JB Case, ES Winkler, Y Liu, LA VanBlargan, J Liu, ...
Nature medicine 27 (4), 717-726, 2021
9072021
Evasion of type I interferon by SARS-CoV-2
H Xia, Z Cao, X Xie, X Zhang, JYC Chen, H Wang, VD Menachery, ...
Cell reports 33 (1), 2020
8612020
Zika virus: History, emergence, biology, and prospects for control
SC Weaver, F Costa, MA Garcia-Blanco, AI Ko, GS Ribeiro, G Saade, ...
Antiviral research 130, 69-80, 2016
7982016
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
JS Turner, JA O’Halloran, E Kalaidina, W Kim, AJ Schmitz, JQ Zhou, T Lei, ...
Nature 596 (7870), 109-113, 2021
6822021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
U Sahin, A Muik, I Vogler, E Derhovanessian, LM Kranz, M Vormehr, ...
Nature 595 (7868), 572-577, 2021
6442021
Neutralizing activity of BNT162b2-elicited serum
Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ...
New England Journal of Medicine 384 (15), 1466-1468, 2021
6422021
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ...
Nature medicine 27 (4), 620-621, 2021
6382021
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ...
Nature 591 (7849), 293-299, 2021
6212021
An infectious cDNA clone of SARS-CoV-2
X Xie, A Muruato, KG Lokugamage, K Narayanan, X Zhang, J Zou, J Liu, ...
Cell host & microbe 27 (5), 841-848. e3, 2020
6162020
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
AB Vogel, I Kanevsky, Y Che, KA Swanson, A Muik, M Vormehr, LM Kranz, ...
Nature 592 (7853), 283-289, 2021
5932021
NS5 of dengue virus mediates STAT2 binding and degradation
J Ashour, M Laurent-Rolle, PY Shi, A García-Sastre
Journal of virology 83 (11), 5408-5418, 2009
5512009
A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity
GP Pijlman, A Funk, N Kondratieva, J Leung, S Torres, L Van der Aa, ...
Cell host & microbe 4 (6), 579-591, 2008
5332008
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ...
Science 373 (6561), 1372-1377, 2021
5282021
A single mutation in the prM protein of Zika virus contributes to fetal microcephaly
L Yuan, XY Huang, ZY Liu, F Zhang, XL Zhu, JY Yu, X Ji, YP Xu, G Li, C Li, ...
Science 358 (6365), 933-936, 2017
4912017
系统目前无法执行此操作,请稍后再试。
文章 1–20